On May 20, 2016 the United Nations held the first ID2020 summit in New York, which is now held annually. The United Nations recognizes “identity as a fundamental human right“, and ID2020 is a strategic, global initiative launched in response to Sustainable Development Goal 16.9., with the aim “by 2030, provide legal identity to all, including birth registration” [1]

“Together we will foster a global conversation and build a working coalition to identify and build the enabling conditions for the creation of a legal digital identity for all individuals at risk“. The UN claims that one fifth of the worlds population is without a recognised legal ID which makes them “invisible to society and vulnerable to trafficking, prostitution, and child abuse.”

Then the ID2020 Alliance launched in 2017 as a global public-private partnership setting the future course of digital identity (ID), ensuring that digital identity is responsibly implemented and widely accessible, as they state no government, company or agency can solve this challenge alone. Its partners include Microsoft, the Rockefeller Foundation, Accenture, GAVI (a core partner of the WHO), UNICEF, the Bill & Melinda Gates Foundation and the World Bank. [2, 3]

On May 27, 2016 the WHO-National Control Laboratory Network for Biologicals (WHO-NNB) was formed. This organisation “brings together national control laboratories and NRAs of vaccine-producing and vaccine recipient countries, WHO contract laboratories, manufacturer’s associations, WHO regional officers and other stakeholders, including donor. WHO-NNB ensures effective use of global resources by providing a platform and infrastructure for collaboration and exchange of information on quality and technical aspecst. It’s main objective is to facilitate access to and the availability of prequalified vaccines (and other biotherapeutic products) through reliance on batch releases by NRAs and national control laboratories that are members of WHO-NNB, thereby reducing redundant testing and encouraging more cost-effective testing and more effective regulatory oversight” [1]

• October 10, 2016  – “Terms of Reference for the first WHO-RIVM Global Vaccine Quality Control Laboratories Networking Meeting  – Building confidence in prequalified vaccines — Accelerated access to vaccines“,
• December 15, 2017 – First general meeting of WHO-NNB – BACKGROUND, REPORT
• WHO do not report any meeting between 2019 (3rd) and 2024 (5th) – HERE

On September 19, 2016 at a United Nation intergovernmental conference in New York on Refugees and Migration, following  July 2016 discussions and on the back the 2015 signing of Agenda 2020, the UN adopted a global compact for safe, orderly and regular migration. Noting that “Forced displacement and irregular migration in large movements… often present complex challenges.”

The drivers of migration are said to include “adverse effects of climate change, natural disasters and human made crises… poverty eradication, conflict prevention and resolution.”  In adopting the 2030 Agenda for Sustainable Development the UN recognized a “positive contribution made by migrants” to their agenda.

The UN documentation on migration dates back to 2013 and 2015, following 2016 stand they revisited their policy position in 2017, 2018 and in 2022.

“In 2018, Member States agreed to review the progress made at the local, national, regional and global levels in implementing the Global Compact for Safe, Orderly and Regular Migration (GCM) in the framework of the United Nations through a State-led approach and with the participation of all relevant stakeholders”

Fast forward to 2022 through this agreement with the Biden administration and the UN the “Global Compact for Migration” creates the infrastructure to facilitate massive free, organised illegal entry into the United States for un-vetted immigrants to invade the United States, including CCP agents and known terrorists. [1, 2, 3, ]

Many countries, including Australia, have been experiencing massive unprecedented immigration since this time, which appears to have escalated since 2021.

Just before the Inauguration of Donald Trump as President, on January 9, 2017 the Obama White House Office of Science and Technology Policy (OSTP) under the direction of John Holdren,  announced policy guideline recommendations that “will satisfy the requirements for lifting the current moratorium on certain life sciences research [gain of function] that could enhance a pathogen’s virulence and/or transmissibility to produce a potential pandemic pathogen (an enhanced PPP).” [1]

These P3CO guidelines were adopted by December 19, 2017, and gain of function resumed – following committee review.

As pointed out by The Highwire, in 1977, John Holdren [2, 3] coauthored the book Ecoscience that discusses the concept of sterilisation as a form of population control, but more alarming is the statement: “Biological warfare laboratories are potential sources of a man-made “solution” to the population explosion.”

Holdren’s co-author is population “alarmist” [4] Paul Ehrlich, who in 1969 published The Population Bomb , which argued to halt population growth predicting people would starve to death years ago – a failed prediction.  In January 2023 Ehrlich returns as an “environmental authority” to “revive his argument that current levels of human consumption” is not sustainable and “will lead to the mass extinction of plants, animals, and mankind itself”.

On January 12, 2017 Moderna, with US Defense Advanced Research Projects Agency (DARPA) funding, began Phase I clinical trials of mRNA-1325 (a Zika vaccine) and was cleared to begin trials of mRNA-1388 (a Chikungunya vaccine). [1]

The following month, DARPA launched the “Pandemic Prevention Platform (P3) program, aimed at developing that foundational work into an entire system capable of halting the spread of any viral disease outbreak before it can escalate to pandemic status.”  This stated intention of end-to-end vaccine platform, or medical countermeasure, is aimed to stop Pandemic X from taking hold, which appears other defense agencies, the Medical Counter Measures Consortium bought into the idea. [2]

“P3 focuses on rapid discovery, characterization, production, testing, and delivery of efficacious DNA- and RNA-encoded medical countermeasures, a foundational technology pioneered by DARPA under the ADEPT program”

““DARPA’s goal is to create a technology platform that can place a protective treatment into health providers’ hands within 60 days of a pathogen being identified, and have that treatment induce protection in patients within three days of administration.”  DARPA believe that these nucleic-acid-based platform apporach for limiting the spread of infection, and would not “integrate into an individual’s genome” and the protein that the bodies cells are forced to make (in this case an antibody not antigen) would only last for “weeks to months“.

The United Nations convened the first World Data Forum (UNWDF) in Cape Town, South Africa on January 15-18, 2017, which has become an annual event.  At the conclusion of the first event, “the Cape Town Global Action Plan for Sustainable Development Data was launched” [1, 2, 3, 6]

“The Forum was organized with the guidance of the UN Statistical Commission and the support of the UN Statistics Division of the UN Department of Economic and Social Affairs (DESA) and the High-level Group for Partnership, Coordination and Capacity-Building for statistics for the 2030 Agenda for Sustainable Development (HLG).”

This platform was used “for intensifying cooperation with various professional groups, such as national statistical offices (NSOs), information technology and geospatial information managers, and data scientists among other representatives of government, intergovernmental organizations and civil society.” [4]  With “particular focus on addressing the monitoring needs of the 2030 Agenda”

“The decision to organize a series of UN World Data Forums followed a recommendation in the report titled, “A World That Counts: Mobilising the Data Revolution for Sustainable Development,” [6] which was presented in November 2014 by the UN Secretary-General’s Independent Expert Advisory Group on a Data Revolution for Sustainable Development” [5]

On day three in the session titled ““Capturing the 21st Century through Data and Algorithms.” Speakers emphasized that the public’s world view and knowledge do not mirror reality, and suggested that schools are better places to create a more fact-based world view than the media; emphasized the value of building narratives from data to steer the narrative to implement the SDGs…”

“Prophetic” quotes from Bill Gates speech [1] at the Munich Security Conference on February 17, 2017 , setting the stage f:

“I decided 20 years ago to make global health the focus of my philanthropic work”…I spend a lot of my time on the effort to eradicate polio…

It’s also true that the next epidemic could originate on the computer screen of a terrorist intent on using genetic engineering to create a synthetic version of the smallpox virus . . . or a super contagious and deadly strain of the flu….The point is, we ignore the link between health security and international security at our peril.

The good news is that with advances in biotechnology, new vaccines and drugs can help prevent epidemics from spreading out of control.

Vaccines can be especially important in containing epidemics. But today, it typically takes up to 10 years to develop and license a new vaccine. To significantly curb deaths from a fast-moving airborne pathogen, we would have to get that down considerably—to 90 days or less.

We took an important step last month with the launch of a new public-private partnership called the Coalition for Epidemic Preparedness Innovations (CEPI). The hope is that CEPI will enable the world to produce safe, effective vaccines as quickly as new threats emerge.

The really big breakthrough potential is in emerging technology platforms that leverage recent advances in genomics to dramatically reduce the time needed to develop vaccines… synthetic genetic material that instructs your cells to make a vaccine inside your own body.  And the great thing is that once you’ve built a vaccine platform for one pathogen, you can use it again for other pathogens. You only need to substitute a few genes.

The third thing we need to do is prepare for epidemics the way the military prepares for war.

It is encouraging that global alliances like the G7 and the G20 are beginning to focus on pandemic preparedness…

Pandemics are everyone’s problem—and as leaders, we cannot ignore it.

…we face today with biological threats. We may not know if that weapon is man-made or a product of nature. But one thing we can be almost certain of.  A highly lethal global pandemic will occur in our lifetimes.

I view the threat of deadly pandemics right up there with nuclear war and climate change.

In an April 27, 2017 press release the first human proof-of-concept data from Moderna’s mRNA technology platform was released. “In addition, they are the first-ever published data demonstrating a prophylactic mRNA vaccine’s ability to elicit robust immunity in humans”.  Moderna distinguishes a “mRNA Therapeutic” from an “mRNA Vaccine” simply by the intent of the protein code, that being to “fight disease” versus “prevent disease”.

In a Cell paper, funded by Moderna Therapeutics, looking at the “immunogenicity by mRNA Vaccines” against H10N8 (mRNA-1440) and H7N9 (mRNA-1851) Influenza Viruses.  They concluded that “LNP-formulated, modified mRNA vaccines can induce protective immunogenicity with acceptable tolerability profiles” in mouse studies and a First-in-Human Phase 1 Study with 31 human subjects (23 of whom received mRNA-1440 and eight of whom received placebo) and were followed for only 43 days, but the intent is for subjects to be “followed for up to 1 year post-vaccination for safety and immunogenicity”. [1, 2, 3]

“mRNA-1440 demonstrated strong efficacy based on Hemagglutination Inhibition Assay (HAI) and Microneutralization Assay (MN) titers, two measures of immunogenicity in response to vaccination.” Achieving antibody “titers consistent with protection at day 43.”

• Clinical trials (NCT03076385 ) began March 2, 2017
• “Adverse events (AEs) according to FDA scale were mild or moderate with 3 subjects (13%) experiencing severe adverse events, it “demonstrated a safety profile consistent with that of approved vaccines”. [4, 5]
• Until recently mRNA vaccines were not advanced into the clinic due to concerns around stability and production.

The paper states that mRNA vaccines “offer advantages in speed, precision, adaptability of antigen design and production control that cannot be replicated with conventional platforms,” and that until recently mRNA vaccines “were not advanced into the clinic due to concerns around stability and production.”

But now with the ever looming “concern for a potential pandemic and the need for an effective, safe, and high-speed, and scalable vaccine production platform, the mRNA-based vaccines make them ideally suited to impede potential pandemic threats.”

World Bank launches first-ever Pandemic Emergency Financing (PEF) Bonds to channel funding to developing countries facing the risk of a pandemic. [1, 2]

At the July 7-8, 2017 G20 Summit, the Berlin Declaration “Together Today for a Healthy Tomorrow” was declared with “seven-page final resolution on pandemic preparedness and antimicrobial resistance.” [1, 2, 3]

Global health , to “leave no one behind”, is top of the G20 agenda.

On June 28, 2017 a coalition of “33 leading Global Health organisations and members of National Parliaments have issued an open letter to G20 Heads of State, to prioritise health and establish the G20 as a permanent global health policy forum.  With a Call to Action strongly urging the G20 to commit investment in research, innovation and development of innovative health technologies to counter threats posed by pandemics, poverty related disese and more. [6, 7]

And so was formed the G20 Health Development Parnership (G20HDP) with the mission “to mobilise, through political, intellectual, social and economic capital, the means required to meet Agenda 2030”. [4, 5]

On September 5, 2017, just 9 months after the launch of CEPI, they put a call out for proposals with the aim to identify new vaccine platform technologies that would enable rapid vaccine development, elicit rapid onset of immunity, and whose production can be scaled-up quickly to respond to the next pandemic disease, soon to be called Disease X.   Funding from B&M Gates Foundation and NIAID.

On October 15, 2019 , CEPI launches a “new call for innovative platform technologies to rapidly respond to Disease X” on the back of the September 2019 GPMB “A World At Risk” report!

On October 23, 2017 The Johns Hopkins Center for Health Security released the SPARS Scenario, a pandemic simulation event, portraying a futureistic scenario for public health risk communicators, where a new virus infects mankind in 2025 and continues until 2028. The self-guided tabletop training experience challenged public health communicators and risk communication researchers to consider the complex messaging dilemmas of a future outbreak, which required the development of a new vaccine. [1, 2]

The fictitious outbreak of the novel SPARS coronavirus is first identified in a major US city in 2025, over 3 years it spreads world wide and the case fatality rates vary depending on the capabilities of local health systems.

In a November 27, 2017 article, the UK calls for parent to get their ‘super spreader’ children in daycare, vaccinated with a free flu jab so that they “protect” their grandparents from the risk of the flu!

The vaccines are simply “assumed” to be safe and effective, yet the CDC state that influenza vaccines are only 40-60% effective, but in some years is as low as 10%!  So what is the real benefit, and at what risk both short and long-term?

It would seem most people don’t realise that influenza & pneumonia statistics are lumped together and advertised as deaths due to flu – its a “death certificate” conundrum.  Flu estimates are based on ever changing models such as Canada’s estimate flu deaths going from 500/yr to 8000/yr.   Every year there are many influenza-like-illness (ILI) which is generally called the flu, but is this yearly flu jabbing actually making things worse? [@45:50] [1]

Doctors are educated by marketers to increase flu-shot demand.  So is this really about health, protection or big-pharma money!

In a private meeting in February 2017, Dr Barney Graham pitched his “brainchild” Prototype Vaccine Project to the NIAID executives which included Dr. Fauci who said the idea struck him and others in the executive committee “as something that is really doable.”

Following that meeting, on December 14, 2017, Dr Graham published a review paper outlining the proposal in Nature Immunology titled “Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic“, in which Fauci provided “editorial comments” and the NIAID supported.  This paper sets the stage for moving forward with “prototype vaccines” for all pathogens with pandemic potential!

The paper stated “developing rational candidate vaccines directed against at least one prototype virus within each major phenotypic category within each family of viruses is advisable”

The paper concluded that “[p]reparation for emerging viral disease will be an inherent component of achieving the United Nations Sustainable Development Goals (UN SDG)”

“But without the urgency of a threatening pandemic, his [Dr Graham‘s] idea remained just that.” stated the New York Times on July 25, 2021, as Fauci seeks funding the “brainchild” project!

In 2018 the Wellcome Trust headed by Jeremy Farrar, released their first Wellcome Global Monitor study of “public attitudes to science and health on a global scale”. Through “conducting nationally representative surveys of people aged 15 years or older in over 140 countries.” [1]

Chapter 5 of the 2018  report covered public perceptions, awareness and attitudes to vaccines, referencing the vaccine confidence index.

Imporving global pandemic preparedness is on their 2025 agenda. [2]

At a annual WHO R&D Blueprint meeting held February 6-7, 2018, “a group of experts” which Peter Daszak belongs to coined the term “Disease X”. They were “referring to the next pandemic, which would be caused by an unknown, novel pathogen that hadn’t yet entered the human population.” and of which there was an “absence of efficacious drugs and/or vaccines”. [1]

The objective of the blueprint and meeting was “to reduce the time between declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, antivirals and other treatments that can save lives and avert a public health crisis”

Disease X would likely:

• Result from a virus originating in animals and would emerge somewhere on the planet where economic development drives people and wildlife together.
• Be confused with other diseases early in the outbreak and would spread quickly and silently; exploiting networks of human travel and trade, it would reach multiple countries and thwart containment.
• Have a mortality rate higher than a seasonal flu but would spread as easily as the flu.
• It would shake financial markets even before it achieved pandemic status.

On October 15, 2019, “CEPI launches new call for innovative platform technologies to rapidly respond to Disease X”, their first call for fast new vaccine platforms went out in 2017.

At Davos 2024 the WEF “preparing for Disease X” with “disinformation” threatens! [2, 3].

On April 10, 2018, Dr Anthony Fauci co-authors a viewpoint paper in JAMA Network setting the stage for novel genetic vaccines (mRNA or DNA) to shorten the time “to design, manufacture, and evaluate vaccines for clinical use…in response to newly emerging infections”.

“The time-honored approach to vaccinology,… has not adequately met” the challenge of “emerging viral diseases with pandemic potential.”  So this paper looks to “exploit modern-day technological advances.”

[Reading this paper in retrospect summarises  the “vaccine solution” response to Pandemic 2020.]

“Historically, the process of vaccine development through to licensure requires decades…[i]n total, 15 to 20 years would be a typical timeframe from virus discovery to vaccine availability if the process proceeds smoothly and there are no major biological or logistical challenges.”

…[H]owever, clinicians and public health officials are often faced with outbreaks of viral diseases, sometimes of a pandemic nature that would require vaccines for adequate control.”

“Rapid genetic sequencing allows both early identification of new pathogens and the identity of the genes encoding structural proteins that can form the basis for vaccine immunogen development.”

“Synthetic vaccinology and platform manufacturing are important innovations that can speed the initial vaccine immunogen design and vaccine development process, and shorten the time needed for manufacturing and initial regulatory approval to begin phase 1 testing.”

“The process of gene synthesis is now extremely rapid…[t]hese genetic vectors (DNA and mRNA) can be used directly for immunization whereby intramuscular immunization leads to muscle cells producing the viral proteins. Alternatively, the genetic vectors can be used to express recombinant protein antigens, in vitro, that can be used for immunization.”

“The term platform …in vaccine production… implies that the method for generating and presenting a vaccine immunogen can be applied across multiple pathogens.”  “DNA or mRNA nucleic acid vaccines are good examples of how platform manufacturing can shorten timelines from pathogen identification to phase 1 clinical trials.” [1, 2]

“DNA vaccine delivery and immunogenicity have evolved and improved over the last 2 decades, making it a viable platform for vaccination.”

Based on NIAID experience “Once these pathogens were identified, the time from viral sequence selection to initiation of the phase 1 clinical trial was shortened from 20 months to slightly longer than 3 months.”

“Traditional approaches, such as live-attenuated virus vaccines (eg, Sabin polio) or whole-inactivated virus vaccines (eg, Salk polio) would not qualify as platform approaches because the requirements for growth in cell culture and purification are usually different among virus families. Protein-based approaches … may not be amenable to platform approaches.”

“Having a standard manufacturing approach reduces the time needed for current Good Manufacturing Procedures process development and simplifies regulatory approval because the safety database that has accumulated for a given platform can be applied to multiple vaccine products.”

Dr Fauci published another paper on “novel vaccine technologies” in Nature in November 2019…all in time for pandemic 2020.

mRNA vaccines are still in “preclinical studies” in September 2018.

On May 15, 2018, hosted by the Johns Hopkins Center for Health Security and held in Washington, DC, high level officials participated in a day-long pandemic tabletop exercise called Clade X. [1, 2]

“Drawing from actual events, Clade X identifies important policy issues and preparedness challenges that could be solved with sufficient political will and attention.”

A fictional elitist cult had financed the creation of a deadly virus called “Clade X ” in a bio-lab in Zurich, with the aim of reducing the global population. A Global pandemic resulted upon it’s fictitious release.

“In the end, the outcome was tragic: the most catastrophic pandemic in history with hundreds of millions of deaths, economic collapse and societal upheaval” — Clade X pandemic simulation (May, 2018)

The simulation concluded that the world wasn’t prepared for a global pandemic.

Bill Gates writes in a NEJM perspective on May 31, 2018, “Thanks to better vaccines” we’ve made headway on diseases.

“Yet there is one area where the world isn’t making much progress: pandemic preparedness. This failure should concern us all, because history has taught us there will be another deadly global pandemic. We can’t predict when, but given the continual emergence of new pathogens, the increasing risk of a bioterror attack, and the ever-increasing connectedness of our world [population growth] , there is a significant probability that a large and lethal modern-day pandemic will occur in our lifetime.”

“What the world needs is a coordinated global approach to pandemics that will work regardless of whether the next pandemic is a product of humans or of nature.”

The percentage of people who choose to get a seasonal influenza vaccine is fairly small, but modelling simulations suggest a “highly contagious and lethal airborne pathogen” could see “33 million people worldwide would die in just 6 months”.

[2 1/2 years into the COVID-19 pandemic 6.3 million deaths have been recorded worldwide]

On May 29, 2018 the Gates foundation “launched a $12 million Grand Challenge … to accelerate the development of a universal influenza vaccine” in order to end the “pandemic threat”.  He noted “the current influenza vaccines significantly underperform.”

“However, the next threat may not be influenza at all.”

Late 2018 CEPI will award grants “to several companies, working with a variety of technologies, including nucleic acid vaccines, viral vectors, and other innovative approaches. The goal is the capability to develop, test, and release new vaccines in a matter of months rather than years.”

“If we can learn how to use RNA or gene delivery effectively, we may not need to make the antibodies at all. Instead, new methods of gene delivery could enable our own cells to produce these antibodies directly.”

“In the case of biologic threats, that sense of urgency is lacking.”  The “world needs to prepare for pandemics in the same serious way it prepares for war.”

On June 8, 2018 the Bill And Melinda Gates Foundations launched a subsidiary, non-profit company, a “biotech-within-a-charity” with an initial $273 million 4-year grant injection.  It is called the Bill & Melinda Gates Medical Research Institute (Gates MRI) and is headquartered in Cambridge, Massachusetts. [1, 2]

The start up company is said to “focus on developing interventions to fight persistent epidemics, such as malaria, tuberculosis, and enteric and diarrheal diseases”.

“Gates MRI hopes to apply new understanding of the human immune system learned from cancer research to prevent infectious disease, and plans to take drugs, vaccines and other assets from preclinical stages all the way through clinical trials to regulatory approval” [3]

On August 10, 2018 the FDA approved  patisiran (Onpattro) by Alnylam pharmaceuticals.  This is a “first-in-class” drug is a small interfering RNA (siRNA) drug that work inside the cell at the RNA level.    The FDA anticipates that [RNA-based Medicine] is the beginning of a new and exciting generation of therapeutics”  [1, 2, 5]

The phase 3 trial included 225 patients with a “rare and frequently fatal” hereditary disease called transthyretin-mediated amyloidosis (hATTR), 148 were given the treatment  [3]

Onpattro drug formulation contains “lipid excipients (DLin-MC3-DMA, DSPC, cholesterol, and PEG2000-C-DMG)”, because of this registration, the lipid nanoparticle ingredient DSPC (1,2-Distearoyl-sn-glycero-3-phosphocholine), which is also used in Pfizer’s mRNA COVID-19 vaccine as a structural lipid, is thus not conidered as “novel”, unlike the functional lipids ALC-0315 and ALC-0159. [4]

On October 9, 2018 the Johns Hopkins Center for Health Secuirty released a report highlighting 15 emerging technologies or categories of technologies, with further scientific attention and investment, as well as attention to accompanying legal, regulatory, ethical, policy, and operational issues have the potential to reduce global catastrophic biological risks (GCBR), as they present “potentially transformative” technologies which would “complement traditional approaches to prevention, preparedness, and response”.  GCBRs is a concept defined in July 2017. The technologies include Self-Spreading Vaccines and Self-Amplifying mRNA Vaccines, and Micro-needle vaccine Patch. [1, 2, 3, 4]

This report highlights 15 technologies or categories of technologies that, with further scientific attention and investment, as well as attention to accompanying legal, regulatory, ethical, policy, and operational issues, could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events.

“This report looks at technologies that are already available but have not been applied to an emergency situation before or are so new that they are still in development”, and “admits there are “substantial technical challenges” in genetically engineering a vaccine but technology such as the Crispr gene editing tool should make the job easier.”

2020 was too early for the self-spreading vaccines, but they are planned to be used for existing infectious diseases!! The WHO knowingly allowed this to occur for polio – they call it vaccine-derived polio!

In December 2018, Moderna became a public listed company via the largest biotech initial public offering (IPO) in history, only to slump through 2019.  Moderna which was founded in 2013, was saved by their COVID-19 vaccine in 2020 as they had never produced a single product before. [1, 2]

On May 10, 2019 Moderna announced the first human studies of mRNA vaccines said to demonstrate “a new technological approach to flu vaccine development and production”. [3]